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Abstract
In this article the authors described the experience of lipofilling usage at the National Cancer Institute. 
Aim of this work was to improve the aesthetic results of surgical treatment of breast cancer patients by the usage of lipofilling 
in patients after breast reconstruction. The description of methods of lipofilling and their application in cancer patients, the benefits 
of usage of LipiVage® system was performed.
Materials and methods. The study included 42 women with breast cancer, who received special treatment in 2012–2016. 
The main group included 21 patients that have received special treatment and undergone lipofilling. The control group included 
21 patients, who received only special treatment, (with no lipofilling). Different objective and subjective criteria for evaluating the 
effectiveness of lipofilling in achieving a satisfactory aesthetic result in patients, who underwent radical and reconstructive surgery 
for breast cancer, were used in this investigation. 
Results shows that the implementation of lipofilling improves the aesthetic perception after breast reconstruction in 20 % of 
patients, decreases the number of complications after reconstructive operations and are not accompanied by a worsening of results 
of special treatment in breast cancer patients. 
In conclusion it can be noted that our results show a high efficiency of lipofilling after special treatment, its safety and ad-
visability for further usage.
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1. Introduction 
Nowadays, there is an important role of reconstructive surgery in breast cancer complex treat-
ment. Lipofilling is one of the modern methods of reconstructive surgery that aims to recover shape, 
volume, contours of breasts, eliminate defects and asymmetry after special surgical treatment. Tech-
nically this is a transplantation of patients’ own fat from different areas (with sufficient reserve of fat) 
to the breast in the required quantity. Lipofilling is a mini-invasive and low-traumatic method which is 
being used more and more often nowadays in routine clinical practice for breasts reconstruction [1–7].
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The key principle in the technique of proper lipofilling performance is atraumatic transplantation 
of intact adipocytes so that to provide the highest survival of cells after the procedure. Cells damage 
during lipofilling causes resorbtion effect, fat doesn’t stay in a breast leading to a need for repeated 
sessions of lipofilling. Lipofilling is mostly performed under general anesthesia. Technically, lipofilling 
procedure has 3 stages: liposuction (fat intake) lipoprocessing (fat processing) and lipoinjections (fat in-
put). The most frequent donor site for fat intake is abdomen, because it contains the largest deposit of fat 
in the human body. Moreover, there is no need to change patient’s position on the operating table. How-
ever, other areas could be chosen individually for each patient: inner thighs, buttocks area, contrlateral 
breast etc. Pressure for liposuction performance should be less than 375 mm Hg so that to minimize ad-
ipocytes damage. To compare, a standard liposuction machine creates negative pressure around 1 atm. 
(760 mm Hg), the same pressure also could be achieved with a syringe. The size of holes in cannula for 
fat intake should be the same as the size of the holes in the cannula for lipoinjections so that to maximize 
efficiency of the procedure (cells flow) and minimize cells damage. The second stage – lipoprocessing – 
is performed to remove blood and any other wastes so that to increase the concentration of clear adipo-
cytes. This leads to better survival of cells and thus durable volume retention after the procedure. There 
are several methods of lipoprocessing – centrifugation, washing, rinsing, deposition and others. Some 
surgeons do not carry out any fat processing. In the Department of Breast Cancer and its’ Reconstructive 
Surgery of National Cancer Institute we use LipiVage® system, which automatically performs filtering 
and concentration of fat during its intake. This disposable system has several advantages comparing to 
other methods of lipofilling. First of all, eliminating the need for any additional fat processing there is no 
time lost, while there is evidence in decrease of adipocytes survival with time. In addition to this, there 
is no contact of fat with the environment, while there is a negative impact of oxygen on adipocytes if 
other methods of lipoprocessing are performed. Furthermore, there are no any other negative physical or 
chemical factors that could lead to cells damage and reduction of their survival. Thus, this system is the 
most conducive for maximum retention of fat after transplantation and minimum risk of complications 
[1, 8]. The third stage – lipoinjections – is an input of an individual volume of fat to the breast. The vol-
ume depends on the surgery aim, the number of planned sessions, physiological features etc. In addition, 
during the input of cannula for lipoinjections to a necessary area, a surgeon mechanically breaks down 
adhesions formed between skin and breast implant, which often occur in one-step mastectomy with 
prepectoral implant-based breast reconstruction. In this case, patients do not develop animation defor-
mities during pectoral muscle tension. This also reduces the risk of such a quite frequent complication 
as capsular contracture (Fig. 1). The same positive effect is observed with subpectoral implant-based 
reconstruction. During the third stage of lipofilling surgeons destroy adhesions between the pectoral 
muscle and implant, respectively [9–11].
In this article the aim of our work was to improve direct results of breast cancer treatment. The 
research is performed at the Department of Oncology, Bogomolets National Medical University at the 
base of the Department of Breast Cancer and its’ Reconstructive Surgery of National Cancer Institute.
                           а                              b                                 c                                d
Fig. 1. The use of lipofilling in the treatment of animation symptom: a – there are adhesions 
between skin and breast implant; b – there are animation deformities during pectoral muscle 
straining; c – during the third stage of lipofilling a surgeon inputs fat and at the same time destroys 
adhesions; d – after lipofilling there are no animation deformities during pectoral muscle tension
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2. Aim of research
The aim of this work was to improve the aesthetic results of surgical treatment of breast 
cancer patients by the usage of lipofilling in patients after breast reconstruction. 
3. Materials and methods
The study includes 42 women with breast cancer (pT1-3 N1-2 M0), who received special treat-
ment in 2012–2016. The average age of patients was 49,5±10,9 years. The main group includes 
21 patients that have received special treatment and undergone lipofilling. The control group in-
cludes 21 patients, who received only special treatment, – it was subcutaneous mastectomy with 
round implant prosthetics (with no lipofilling). In the main group lipofilling was held as the final 
stage of breast reconstruction after the following breast cancer surgeries: subcutaneous mastecto-
my with one-step round implant prosthetics – 16 (76,2 %), mastectomy with one-step TDL breast 
reconstruction – 2 (9,5 %), mastectomy with one-step TRAM breast reconstruction – 3 (14,3 %). 
Each patient had 1,86±0,65 sessions of lipofilling (1 to 3 sessions). Average transplanted volume 
was 105,2±50,26 ml (minimum 60 ml, 250 ml maximum). The median of lipofilling performance 
was in 12 months after special surgical treatment. For lipofilling conduction patients were in the 
hospital for one day. Follow-up median was 20 months.
To assess the efficiency of lipofilling in the National Cancer Institute clinic we made a survey 
of patients in 3 months after lipofilling in the main group and at the analogical time in the control 
group. Lipofilling efficiency was evaluated in general and by special parameters. These parameters 
are breast resilience, volume, shape, skin elasticity, skin turgor, absence of deformations and symme-
try of breasts. In the questioning a 5-point scale was used: 5 – very good, 4 – good, 3 – satisfactory, 
2 – bad, 1 – very bad. The significance of the difference between the state of these parameters in 
points before and in 3 moths after lipofilling holding was evaluated using Student’s t-test. 
After that, every patient was evaluated with a LENT-SOMA scale. This scale includes a 
subjective parameter – pain, and four objective parameters – telangiectasia, edema, fibrosis and 
atrophy [1, 3]. These parameters were estimated in the following way (Table 1).
Table 1
LENT-SOMA scale
Points 1 2 3 4
Subjective parameter of LENT-SOMA scale
Pain Periodic and minimum  hypersensitivity, itching
Periodic and  
tolerant pain Constant and intensive pain
Unbearable pain,  
poorly treated
Objective parameters of LENT-SOMA scale
Teleangiectasia <1 cm2 1–4 cm2 >4 cm2
Edema Asymptomatic Symptomatic Secondary dysfunction
Atrophy 10–25 % >25–40 % >40–75 % Full breast
Fibrosis Increased density, barely palpable
Certain increase in 
density and hardness
Highly expressed density, retrac-
tion, fixation
The significance of the difference between LENT-SOMA scale parameters state (in points) 
before and in 3 moths after lipofilling holding was also evaluated using Student’s t-test. 
Safety assessment was conducted by the appearance of complications or disease progression 
after lipofilling performance during the observation period.
4. Results of research
According to the survey replies, in the main group most patients rated their breast condition 
as good – 12 (57 %); very good – 3 (14 %), satisfactory – 6 (29 %). None of the patients assessed 
the state of breast as bad or very bad (Fig. 2). In the control group, 9 patients (43 %) rated their 
condition as good, 8 (38 %) – as satisfactory, 3 (14 %) – as bad and 1 (5 %) – as very bad. None of 
the patients in the control group gave an answer “very good” (Fig. 3). In addition to that, patients 
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of the main group were asked a question on how do they assess breast condition after lipofilling 
undergoing, compared to the state before it is held. A reply “better” gave 14 patients (67 %), “much 
better” – 4 (19 %) and “same” – 3 (14 %). There were no patients who experienced worsening of 
their breast state (Fig. 4).
Fig. 2. Main group patients’ evaluation of their breast state in 3 months after lipofilling 
Fig. 3. Control group patients’ evaluation of their breast state
Fig. 4. Main group patients’ evaluation of their breast state in comparison with  
the state before lipofilling
Table 2 represents questioning results of main group patients by specific parameters. The 
table shows that in 3 months after lipofilling, patients experienced significant improvement of all 
these parameters. There was an improvement of breasts resilience (score on a 5-point scale before 
was 2,24±0,7, and after it was 3,62±0,74, p<0,01), volume (before 1,95±0,74, after 3,81 ± 0,87, p<0,01), 
form (before 1,57±0,51, after 3,67±0,73, p<0.01), skin elasticity (before 2,57±0,51, after 3,14±0,96, 
p<0,05), skin turgor (before 1,86±0,73 after 3,38±0,86, p<0,01), absence of defects (before 2,05±0,8, 
after 3,29±0,85, p<0,01), and symmetry of breasts (before 1,62±0,59, after 3,76±0,94, p<0,01). 
The results of patients’ functional assessment with LENT-SOMA scale are shown in 
Table 3. There we can see a significant decrease of pain intensity (before 0,95±0,8, after 
0,52±0,51, p<0,05), teleangiectasia (before 1,14±0,79, after 0,71±0,56, p<0,05), atrophy (before 
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1,81±0,93, after 1,1±0,89, p<0,05), edema (before 1,48±0,87, after 0,95±0,8, p<0,05) and fibro-
sis (before 2,05±0,97, after 1,48±0,75, p<0,05). 
Table 2
Questioning results of the main group patients
Parameter Before lipofilling, points 3 months after lipofilling, points p
1 Resilience 2,24±0,7 3,62±0,74 <0,01
2 Volume 1,95±0,74 3,81±0,87 <0,01
3 Shape 1,57±0,51 3,67±0,73 <0,01
4 Skin elasticity 2,57±0,51 3,14±0,96 <0,05
5 Skin turgor 1,86±0,73 3,38±0,86 <0,01
6 Absence of deformations 2,05±0,8 3,29±0,85 <0,01
7 Symmetry of breasts 1,62±0,59 3,76±0,94 <0,01
Table 3
LENT-SOMA scale evaluation results of the main group patients
Parameter Before lipofilling, points 3 months after lipofilling, points p
1 Pain 0,95±0,8 0,52±0,51 <0,05
2 Teleangiectasia 1,14±0,79 0,71±0,56 <0,05
3 Atrophy 1,81±0,93 1,1±0,89 <0,05
4 Edema 1,48±0,87 0,95±0,8 <0,05
5 Fibrosis 2,05±0,97 1,48±0,75 <0,05
There were no complications or locoregional recurrences in the main group patients during 
the observation period, while in the control group there was one case of capsular contracture. Thus, 
the rate of complications in the study group was 0 %, and in the control group this rate was 5 %. 
5. Discussion of results
According to subjective estimates of the patients lipofilling significantly increased the per-
centage of patients satisfied with the aesthetic result of surgical treatment. We observed a statis-
tically significant difference between the groups of patients’ perception of elasticity, volume and 
shape of the breasts, elasticity and turgor of their skin, absence of defects and symmetry. Fat graft-
ing significantly reduced the number of complications after breast reconstruction (edema, fibrosis, 
atrophy of the skin, telangiectasia, pain). We believe lipofillig is an ideal tool for elimination the 
symptom of the animation after breast reconstruction with implant. Most likely, this is not only 
a mechanical separation of the skin from the scar, thickening of the subcutaneous layer, but also 
the active influence of the proteolytic enzymes, which makes the breast more natural. Almost fat 
grafting was a universal procedure to correct minor deformities and asymmetries of the breasts 
that is difficult to correct by other methods. In addition, it does not have the complications that oc-
cur with other methods of correction of breasts. It should also be noted that this procedure did not 
worsen the long-term results of treatment of patients with breast cancer and was not accompanied 
by complications.
These results indicate lipofilling’s safety, however, further long-term follow-up is for sure 
required. The literature data also show a low incidence of complications or locoregional recur-
rences. The most common complications are liponecrosis, oleogranulomas, calcifications, cysts 
formation, infections, insufficient or excessive correction. Less frequent complications are implant 
damage, pneumothorax, intravascular injection with embolism. There are also doubts concerning 
an interaction between transplanted fat and tumor cells [12–22].
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6. Conclusions
Lipofilling is successfully used as a final stage of breast cancer reconstructive surgery. This 
is a mini-invasive, low-impact, effective and safe method. Lipofilling provides thorough remov-
al of tissue defects, asymmetry or other disadvantages after special surgical treatment, improves 
the quality of patients’ life. Lipofilling does not require a long-term stay of a patient in a hospital 
(1 day). This method does not affect the main disease process. Lipofilling prevents capsular con-
tracture development after subcutaneous mastectomy with implant prosthetics. 
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